TLR4 and Sepsis: Overexpression of miR-22 could target and suppress the expression of HMGB1, inhibit the release of inflammatory factors and the expression of HMGB1/TLR4/NF-κB signaling pathway-related proteins, to attenuate the sepsis-induced AKI.